Use of Statins in Patients With and Without Liver Disease.
作者信息
Francis Prashanth, Forman Lisa
机构信息
Division of Gastroenterology and Hepatology University of Colorado Anschutz Medical Campus Aurora CO.
出版信息
Clin Liver Dis (Hoboken). 2020 Feb 25;15(1):40-45. doi: 10.1002/cld.866. eCollection 2020 Jan.
Abstract
摘要
相似文献
1
Use of Statins in Patients With and Without Liver Disease.他汀类药物在有肝病和无肝病患者中的应用。
Clin Liver Dis (Hoboken). 2020 Feb 25;15(1):40-45. doi: 10.1002/cld.866. eCollection 2020 Jan.
2
Nonalcoholic fatty liver disease and statins.非酒精性脂肪性肝病与他汀类药物
Metabolism. 2015 Oct;64(10):1215-23. doi: 10.1016/j.metabol.2015.07.003. Epub 2015 Jul 8.
3
The Use of Statins in Patients With Chronic Liver Disease and Cirrhosis.他汀类药物在慢性肝病和肝硬化患者中的应用。
Curr Treat Options Gastroenterol. 2018 Jun;16(2):226-240. doi: 10.1007/s11938-018-0180-4.
4
Liver function tests and statins.肝功能检查与他汀类药物
Curr Opin Cardiol. 2011 Jul;26(4):338-41. doi: 10.1097/HCO.0b013e328347036f.
5
Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits.给患有肝脏疾病的血脂异常患者开具他汀类药物处方：风险与获益之间的微妙平衡。
Nutr Metab Cardiovasc Dis. 2004 Aug;14(4):215-24. doi: 10.1016/s0939-4753(04)80008-5.
6
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study.他汀类药物治疗非酒精性脂肪性肝病和慢性肝酶升高：一项组织病理学随访研究
J Hepatol. 2007 Jul;47(1):135-41. doi: 10.1016/j.jhep.2007.02.013. Epub 2007 Mar 8.
7
Effects of statins on the liver: clinical analysis of patients with ischemic stroke.他汀类药物对肝脏的影响：缺血性脑卒中患者的临床分析。
Chin Med J (Engl). 2011 Mar;124(6):897-900.
8
Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.他汀类药物在慢性肝病和肝硬化患者中的应用：当前观点与前景
Curr Gastroenterol Rep. 2017 Sep;19(9):43. doi: 10.1007/s11894-017-0584-7.
9
Pleiotropic effects of statins in the diseases of the liver.他汀类药物在肝脏疾病中的多效性作用。
World J Gastroenterol. 2016 Jul 21;22(27):6201-13. doi: 10.3748/wjg.v22.i27.6201.
10
Statins and Abnormal Liver Enzymes.他汀类药物与肝功能异常酶
S D Med. 2019 Jan;72(1):12-14.
引用本文的文献
1
Nrf2/HO-1, NF-κB and PI3K/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats.Nrf2/HO-1、NF-κB 和 PI3K/Akt 信号通路解析了匹伐他汀在大鼠早期肝纤维化阶段的治疗机制。
J Cell Mol Med. 2024 Feb;28(3):e18116. doi: 10.1111/jcmm.18116. Epub 2024 Jan 12.
2
Cardiac Syndromes in Liver Disease: A Clinical Conundrum.肝病中的心脏综合征：一个临床难题。
J Clin Transl Hepatol. 2023 Aug 28;11(4):975-986. doi: 10.14218/JCTH.2022.00294. Epub 2023 Feb 1.
3
The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma.治疗高胆固醇血症利大于弊：他汀类药物困境
Cureus. 2023 Jan 11;15(1):e33648. doi: 10.7759/cureus.33648. eCollection 2023 Jan.
4
Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase.丙氨酸氨基转移酶升高患者使用他汀类药物与严重急性肝损伤
Clin Epidemiol. 2022 Dec 14;14:1535-1545. doi: 10.2147/CLEP.S385712. eCollection 2022.
5
Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association: Endorsed by the American Society of Transplantation.新兴的肾和肝移植候选者冠心病筛查证据：美国心脏协会的科学声明：得到美国移植学会的认可。
Circulation. 2022 Nov 22;146(21):e299-e324. doi: 10.1161/CIR.0000000000001104. Epub 2022 Oct 17.
6
Statins Show Promise Against Progression of Liver Disease.他汀类药物有望对抗肝病进展。
Clin Liver Dis (Hoboken). 2021 Dec 20;18(6):280-287. doi: 10.1002/cld.1143. eCollection 2021 Dec.
本文引用的文献
1
Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy.原发性胆汁性胆管炎中的高脂血症：治疗、安全性及疗效
Frontline Gastroenterol. 2019 Oct;10(4):401-408. doi: 10.1136/flgastro-2018-101124. Epub 2019 Jan 9.
2
Management of dyslipidemia in adult solid organ transplant recipients.成人实体器官移植受者血脂异常的管理。
J Clin Lipidol. 2019 Mar-Apr;13(2):231-245. doi: 10.1016/j.jacl.2019.01.011. Epub 2019 Jan 30.
3
Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.阿托伐他汀对肝硬化门静脉高压患者门静脉血流动力学及临床结局的影响：一项概念验证性研究
Eur J Gastroenterol Hepatol. 2018 Jan;30(1):54-59. doi: 10.1097/MEG.0000000000001006.
4
Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study.酒精性肝硬化患者使用他汀类药物可降低失代偿和死亡风险。一项全国性病例队列研究。
Aliment Pharmacol Ther. 2017 Oct;46(7):673-680. doi: 10.1111/apt.14243.
5
Statin therapy in patients with cirrhosis.肝硬化患者的他汀类药物治疗。
Frontline Gastroenterol. 2015 Oct;6(4):255-261. doi: 10.1136/flgastro-2014-100500. Epub 2014 Aug 8.
6
Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.他汀类药物的使用与慢性肝病患者肝硬化及相关并发症风险的关系：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1521-1530.e8. doi: 10.1016/j.cgh.2017.04.039. Epub 2017 May 4.
7
Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.他汀类药物降低乙型肝炎病毒和丙型肝炎病毒相关肝硬化失代偿的风险：一项基于人群的研究。
Hepatology. 2017 Sep;66(3):896-907. doi: 10.1002/hep.29172. Epub 2017 May 8.
8
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.他汀类药物与心血管疾病患者使用的特定药物之间具有临床意义的药物相互作用的管理建议：美国心脏协会的科学声明
Circulation. 2016 Nov 22;134(21):e468-e495. doi: 10.1161/CIR.0000000000000456. Epub 2016 Oct 17.
9
Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.他汀类药物可降低HIV/丙型肝炎病毒合并感染个体发展为肝硬化的进程。
AIDS. 2016 Oct 23;30(16):2469-2476. doi: 10.1097/QAD.0000000000001219.
10
Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.他汀类药物降低慢性乙型肝炎患者肝硬化及其失代偿风险：一项全国性队列研究。
Am J Gastroenterol. 2016 Jul;111(7):976-85. doi: 10.1038/ajg.2016.179. Epub 2016 May 10.
Zotero 插件